If you have a history of breast cancer and a mutation in the ATM gene, you may be eligible to contribute to tumor genomics studies to help better understand inherited breast cancer in ATM carriers. Through the Inherited Cancer Registry (ICARE), we are studying:
- breast cancer characteristics
- factors associated with outcomes, including treatments
- tumor genomics to better understand pathways to tumor development
With your help, we hope that one day our research may lead to new or refined treatment strategies! To learn more about participating in ICARE or if you’d like to enroll online, please visit https://inheritedcancer.net/. Once you are enrolled into ICARE, our research team will assess your eligibility for this and other focused research efforts.